Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo

Authors
Publication date
1 January 2010
Publisher
Springer-Verlag
Doi
    View on PubMed

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Springer - Publisher Connector

      redirect
      Last time updated on 03/05/2017

      Springer - Publisher Connector

      redirect
      Last time updated on 05/06/2019

      Crossref

      redirect
      Last time updated on 31/03/2019